Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) in Healthy Subjects Aged 9 Months to 55 Years in Vietnam
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 10 Oct 2017 Status changed from recruiting to completed.
- 07 Jun 2016 Planned End Date changed from 1 Feb 2017 to 1 Dec 2017.
- 07 Jun 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Apr 2017.